AxiDerm™ Suite 
Every microdecision.
Built into a tool.

Otic AxiDerm™
Select an ideal ear drop based on your cytology

Ear Cleaning AxiDerm™
Cleanser selection by cytology and anatomy

Ear Severity Score
Structured scoring for otitis grading and tracking

Medication AxiDerm™
Map CAD drugs on Dr. Painter’s Inflammation First® itch and inflammation axes

Steroid Taper Tool
BW-based dosing, tapering schedules, breed flags

Cyclosporine Startup
Formulation selection, dosing, and client counseling

Fatty Acid Dose Calc
EPA/DHA dosing by weight and product content

Supplement Guide
Evidence-based supplement recommendations for CAD

Antihistamine Reality Check
When they work — and when they don’t

Drug Combination Safety
Oclacitinib, ciclosporin & steroid risk checker

Pyoderma Treatment
Antibiotic selection, duration, topical pairing

MRSP Interpreter
Culture result interpretation for resistant staph

MRSP Risk Calculator
Pre-culture risk stratification for resistant infection

Scabies Check
Clinical likelihood scoring for sarcoptic mange

Allergic Dog or Not?
Structured triage to distinguish CAD from other pruritic disease

Diet Trial Readiness
Patient readiness, diet selection, and client prep

Allergen Testing Checkpoint
Decide if your patient is a good candidate for an allergy test

Referral Check
When to refer — criteria, timing, how to frame it

Pattern Hunter
Structured triage to distinguish CAD from other pruritic disease

Flare Tracker
Longitudinal flare logging with treatment response notes

Topical Therapy Selector
Shampoo type, bathing frequency, and post-bath care by lesion

Flea Control Selector
Bathing frequency, flea burden & coat type–driven recommendations

If you survived veterinary school, you can use AxiDerm™. Every tool is built to be used on first open — no onboarding, no training, no learning curve. I respect your time, and I've made this as easy as possible.

Drug references tell you what exists. They don't tell you whether this patient needs Cytopoint or Zenrelia, how to stage a Pseudomonas case, or whether this owner is actually ready for a diet trial. AxiDerm™ doesn't replace your references or your clinical judgment — it supports the way you already think, so you can practice with support.

Because Zenrelia® was approved in September 2024. Numelvi™ in February 2026. ISCAID guidelines get revised. A tool you buy once is a tool that ages out. A subscription means what you open on Tuesday reflects where the evidence actually is — not where it was when someone wrote a textbook chapter.

You see allergic dogs five days a week. At the founding rate, AxiDerm™ costs less than $2 a day. If it changes how you approach one Cytopoint vs. Zenrelia decision, one ear recheck, one diet trial conversation — it's already paid for itself. Seven days free to find out.

No. Every recommendation in AxiDerm™ is built on a deterministic clinical framework — my framework, based on current evidence, published guidelines, and 10+ years in referral practice. No language model. No hallucinations. No confident-sounding answers that aren't  rounded in anything real. The tool does exactly what I designed it to do, every time.